HAE Jul 2024 90.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 11:47AM EDT
Loading interactive chart...
- Zacks
Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Haemonetics (HAE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Zacks
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
Boston Scientific, ResMed, Lantheus and Haemonetics are part of the Zacks Industry Outlook article.
- Zacks
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
Haemonetics (HAE) expands its VASCADE portfolio with the limited market release of VASCADE MVP XL vascular closure device.
© 2024 Yahoo. All rights reserved.